Cancer immunotherapy has emerged as a powerful treatment option characterized by durable remissions and tolerable side effects.
In recent years, an unprecedented number of immune-based therapeutic modalities have been approved in the first- and second-line as well as in the adjuvant setting across a growing number of malignancies. This influx of approvals has created a need to stay current on the latest recommendations for the appropriate application of immunotherapy.
SITC Cancer Immunotherapy CONNECT is your hub to participate in live and online educational opportunities to learn more about integrating cancer immunotherapy into your practice. Download a variety of resources in the SITC Resource Library and connect with other clinicians in the Cancer Immunotherapy CONNECT Open Forum to learn more about the latest approvals, patient selection criteria, relevant biomarkers and immune-related adverse events.
LUNG FORCE Expo The LUNG FORCE Expo is a program designed for healthcare providers to learn more about the latest trends, resources and research surrounding lung cancer, COPD, and ...
3rd NEW HORIZONS IN IMMUNOTHERAPY Sponsored by UPMC Center for Continuing Education in the Health Sciences and UPMC Hillman Cancer Center Renaissance Pittsburgh Hotel 107 6 ...
My understanding is that immune monitoring assays must be optimized with the goal of focusing on a specific approach that provides in vivo results that are relevant . This leads to meaningful ...
We have been interested in the TME and assaying with CLIA approved tests to inform us about combination immune therapy and have recently published on this area, see below. OmniSeq, a molecular ...
View More Clinician Resources
In this video, hear SITC Annual Meeting delegates explain the purpose and benefits for joining thousands of their colleagues at the Annual Meeting & Pre-Conference Programs, share how far the science of cancer immunotherapy has progressed and predict where the field is headed. Also, learn about the benefits of becoming a member of SITC.
For more than 30 years SITC (Society for Immunotherapy of Cancer) has been fighting for treatment and a cure for cancer through research and collaboration. SITC members all over the world are leading the charge against cancer. We’re traveling the globe to meet these thought leaders and demonstrate the crucial work that they’re doing to impact advances in both the science and clinical application of immunotherapy.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com